Letter comments on anti-PD(L)1 immunotherapies in patients with cancer and with pre-existing systemic sclerosis: a post-marketed safety assessment study.

Authors	Satoshi Ikeda, Yukie Yamaguchi, Tomohisa Baba, Akimasa Sekine, Takashi Ogura
Journal	European journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 165 Pg. 205-207 (04 2022) ISSN: 1879-0852 [Electronic] England
PMID	35232628 (Publication Type: Letter, Comment)
Topics	Humans Immunotherapy (adverse effects) Neoplasms (drug therapy) Scleroderma, Systemic (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!